US Patent Issued to Boehringer Ingelheim International on Oct. 7 for "Pharmaceutical composition, methods for treating and uses thereof" (German, American, Swiss Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,906, issued on Oct. 7, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Pharmaceutical composition, methods for treating and uses thereof" was invented by Uli Christian Broedl (Mainz, Germany), Sreeraj Macha (Basking Ridge, N.J.), Maximilian von Eynatten (Erding, Germany) and Hans-Juergen Woerle (Cully, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD)."

The patent was ...